CDRH Looks Ahead, And Behind, On Guidance Development
This article was originally published in The Gray Sheet
Executive Summary
The device center issued its standard "A list" and "B list" guidance priorities for fiscal year 2015, and unveiled plans to systematically reassess published guidance documents and seek technical feedback on future guidance topics.
You may also be interested in...
CDRH Sets Performance Goals To Reduce Draft Guidance Ambiguity
The device center has committed to metrics for draft guidance documents, trying to address complaints that policies linger too long in the draft stage and create regulatory confusion. CDRH also highlighted recent website upgrades intended to better distinguish between draft and final guidance documents.
Clinical Labs Lawyer Up In Battle Over LDTs
ACLA has recruited Laurence Tribe and Paul Clement, two prominent constitutional legal guns with Supreme Court expertise, to fight FDA over its proposed lab-developed test guidance. The announcement is perhaps the lab industry's most high profile move yet to oppose FDA's plan to regulate lab-developed test services under the device statute with a risk-based phase-in plan.
Active Months Ahead For mHealth Regulatory Policymaking
Multiple guidances, frameworks and legislative activity on mHealth are expected to surface this fall and could have major implications on how the emerging industry is regulated.